Cannabis Rescheduling Update: Everything You Need to Know
Stay informed with the latest update on the rescheduling of cannabis and understand its implications for purchasing THC products online.
The latest cannabis rescheduling news is simple to state: the DEA's proposal to move marijuana from Schedule I to Schedule III is still in formal review and has not taken effect. No federal reclassification has been signed, which means cannabis remains a controlled substance federally while states continue to run their own medical and adult-use programs. The most meaningful change so far is procedural: the proposal has entered an administrative hearing phase, where an administrative law judge takes testimony and writes a recommendation before the DEA administrator decides whether to issue a final rule.
What rescheduling means in plain terms
Rescheduling is not legalization. It changes which controlled substance schedule a drug sits in under the federal Controlled Substances Act.
How Does Cannabis Rescheduling Affect Medical Use?
- Schedule I is reserved for drugs with no currently accepted medical use and a high potential for abuse. Marijuana has been there since 1970.
- Schedule III covers drugs with a currently accepted medical use, moderate to low physical dependence risk, and high psychological dependence risk. Ketamine and anabolic steroids sit in this group.
Moving marijuana to Schedule III would acknowledge medical value at the federal level. It would not create a legal recreational market.
How the process reached this point
- August 2023: The Department of Health and Human Services completed a scientific review and recommended that marijuana be moved to Schedule III.
- May 2024: The DEA published a proposed rule in the Federal Register to reclassify marijuana and opened a public comment period.
- July 2024: The public comment window closed, drawing a large volume of submissions.
- 2025: The DEA placed the proposal into a formal administrative hearing process rather than issuing a final rule outright.
That hearing stage matters. It adds testimony, cross-examination, and briefing before an administrative law judge issues a recommended decision. Only then does the DEA administrator sign or reject a final rule, and any final rule can still be challenged in federal court.
latest cannabis rescheduling news
What a Schedule III listing would change
- Tax treatment: State-licensed cannabis businesses would no longer face the Section 280E restriction that blocks most ordinary business deductions for companies trafficking in Schedule I or II substances.
- Research: Researchers would face fewer registration and sourcing barriers when studying cannabis.
- Banking and capital: Lenders and financial institutions may find it easier to work with licensed operators, though federal banking law changes would still be needed for a full fix.
- Regulatory oversight: The FDA could take a larger role in medical cannabis products, including labeling and dosing standards.
What it would not change
- Recreational cannabis would remain federally illegal. Schedule III drugs are still controlled substances.
- Possession without a valid prescription would still carry federal exposure.
- State borders would stay closed to cannabis transport. Interstate commerce would not open up.
- State licensing, testing, and possession limits would keep governing retail sales.
What to watch next
- The administrative law judge's recommended decision and the reasoning behind it.
- The DEA administrator's final rule, which could be signed, revised, or declined.
- Court appeals, which can pause implementation even after a final rule.
- Congress, where standalone bills on banking access and federal reform continue to move separately from the rescheduling docket.
What this means if you buy cannabis in a legal state
Nothing changes at the register right now. Federal scheduling does not override state law in either direction, so licensed dispensaries in medical and adult-use states operate under the same rules they did before the proposal. Practical guidance stays the same: buy from licensed retailers, stay within your state's possession limits, do not carry cannabis across state lines, and treat federal property such as airports and national parks as off limits.
Because this is an active federal proceeding, details can shift with each filing. Check the Federal Register docket and DEA announcements for the official status rather than relying on headlines.